Ogorek Anthony Joseph’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8K Hold
98
﹤0.01% 443
2026
Q1
$7K Hold
98
﹤0.01% 431
2025
Q4
$8K Sell
98
-17
-15% -$1.4K ﹤0.01% 402
2025
Q3
$8K Buy
115
+3
+3% +$234 ﹤0.01% 426
2025
Q2
$8K Buy
112
+19
+20% +$1.42K ﹤0.01% 409
2025
Q1
$6K Buy
+93
New +$6.66K ﹤0.01% 437
2023
Q4
Sell
-165
Closed -$11K 291
2023
Q3
$11K Hold
165
﹤0.01% 198
2023
Q2
$15K Sell
165
-314
-66% -$27.3K 0.01% 177
2023
Q1
$39K Sell
479
-1,305
-73% -$103K 0.02% 113
2022
Q4
$133K Hold
1,784
0.06% 63
2022
Q3
$147K Hold
1,784
0.07% 57
2022
Q2
$169K Hold
1,784
0.08% 57
2022
Q1
$210K Hold
1,784
0.09% 53
2021
Q4
$231K Hold
1,784
0.1% 49
2021
Q3
$201K Buy
1,784
+314
+21% +$35.8K 0.09% 48
2021
Q2
$152K Hold
1,470
0.07% 55
2021
Q1
$122K Hold
1,470
0.06% 56
2020
Q4
$135K Hold
1,470
0.07% 40
2020
Q3
$117K Hold
1,470
0.07% 40
2020
Q2
$102K Sell
1,470
-270
-16% -$19.2K 0.07% 34
2020
Q1
$109K Buy
1,740
+990
+132% +$71.4K 0.06% 29
2019
Q4
$58K Hold
750
0.03% 42
2019
Q3
$54K Hold
750
0.03% 39
2019
Q2
$46K Buy
750
+480
+178% +$29K 0.03% 38
2019
Q1
$17K Hold
270
0.01% 74
2018
Q4
$13K Hold
270
0.01% 84
2018
Q3
$15K Buy
+270
New +$13.2K 0.01% 77

Other funds holding EW

Ogorek Anthony Joseph's EW Position: Q2 2026 in Review

Ogorek Anthony Joseph held its Edwards Lifesciences (EW) position steady in Q2 2026 at 98 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Ogorek Anthony Joseph first reported a position in EW in Q3 2018 and has held it in 27 quarters since. The position peaked at $231K in Q4 2021. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ogorek Anthony Joseph held 98 shares of Edwards Lifesciences worth $8K as of Q2 2026.
  • Ogorek Anthony Joseph left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #443 holding.
  • Ogorek Anthony Joseph first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 27 quarters since.
  • Ogorek Anthony Joseph's Edwards Lifesciences position peaked at $231K in Q4 2021.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.